| UniProt ID | RS25_HUMAN | |
|---|---|---|
| UniProt AC | P62851 | |
| Protein Name | 40S ribosomal protein S25 | |
| Gene Name | RPS25 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 125 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MPPKDDKKKKDAGKSAKKDKDPVNKSGGKAKKKKWSKGKVRDKLNNLVLFDKATYDKLCKEVPNYKLITPAVVSERLKIRGSLARAALQELLSKGLIKLVSKHRAQVIYTRNTKGGDAPAAGEDA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | 2-Hydroxyisobutyrylation | GKSAKKDKDPVNKSG CHHCCCCCCCCCCCC | 73.19 | - | |
| 25 | Ubiquitination | KDKDPVNKSGGKAKK CCCCCCCCCCCHHCC | 51.19 | 33845483 | |
| 26 | Phosphorylation | DKDPVNKSGGKAKKK CCCCCCCCCCHHCCC | 47.80 | 28258704 | |
| 29 | Ubiquitination | PVNKSGGKAKKKKWS CCCCCCCHHCCCCCC | 61.63 | - | |
| 37 | Ubiquitination | AKKKKWSKGKVRDKL HCCCCCCCCCHHHHH | 62.73 | 23000965 | |
| 39 | Ubiquitination | KKKWSKGKVRDKLNN CCCCCCCCHHHHHHC | 37.52 | 23000965 | |
| 43 | Acetylation | SKGKVRDKLNNLVLF CCCCHHHHHHCEEEE | 42.42 | 23236377 | |
| 43 | Sumoylation | SKGKVRDKLNNLVLF CCCCHHHHHHCEEEE | 42.42 | - | |
| 43 | Ubiquitination | SKGKVRDKLNNLVLF CCCCHHHHHHCEEEE | 42.42 | 23000965 | |
| 52 | Succinylation | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | - | |
| 52 | Succinylation | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | - | |
| 52 | 2-Hydroxyisobutyrylation | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | - | |
| 52 | Ubiquitination | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | 23000965 | |
| 52 | Malonylation | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | 26320211 | |
| 52 | Acetylation | NNLVLFDKATYDKLC HCEEEEEHHHHHHHH | 34.98 | 19608861 | |
| 54 | Phosphorylation | LVLFDKATYDKLCKE EEEEEHHHHHHHHHH | 37.68 | 28152594 | |
| 55 | Phosphorylation | VLFDKATYDKLCKEV EEEEHHHHHHHHHHC | 18.88 | 28152594 | |
| 57 | Malonylation | FDKATYDKLCKEVPN EEHHHHHHHHHHCCC | 45.42 | 26320211 | |
| 57 | Ubiquitination | FDKATYDKLCKEVPN EEHHHHHHHHHHCCC | 45.42 | 23000965 | |
| 57 | Acetylation | FDKATYDKLCKEVPN EEHHHHHHHHHHCCC | 45.42 | 25953088 | |
| 60 | Malonylation | ATYDKLCKEVPNYKL HHHHHHHHHCCCCEE | 72.66 | 26320211 | |
| 60 | Ubiquitination | ATYDKLCKEVPNYKL HHHHHHHHHCCCCEE | 72.66 | 23000965 | |
| 60 | Acetylation | ATYDKLCKEVPNYKL HHHHHHHHHCCCCEE | 72.66 | 19608861 | |
| 65 | Phosphorylation | LCKEVPNYKLITPAV HHHHCCCCEECCHHH | 10.91 | - | |
| 66 | Acetylation | CKEVPNYKLITPAVV HHHCCCCEECCHHHH | 39.80 | 19608861 | |
| 66 | 2-Hydroxyisobutyrylation | CKEVPNYKLITPAVV HHHCCCCEECCHHHH | 39.80 | - | |
| 66 | Ubiquitination | CKEVPNYKLITPAVV HHHCCCCEECCHHHH | 39.80 | 23000965 | |
| 66 | Methylation | CKEVPNYKLITPAVV HHHCCCCEECCHHHH | 39.80 | 22635435 | |
| 66 | Malonylation | CKEVPNYKLITPAVV HHHCCCCEECCHHHH | 39.80 | 26320211 | |
| 69 | Phosphorylation | VPNYKLITPAVVSER CCCCEECCHHHHCHH | 18.68 | - | |
| 74 | Phosphorylation | LITPAVVSERLKIRG ECCHHHHCHHHHHCH | 15.48 | 26074081 | |
| 82 | Phosphorylation | ERLKIRGSLARAALQ HHHHHCHHHHHHHHH | 14.70 | 29514088 | |
| 93 | Phosphorylation | AALQELLSKGLIKLV HHHHHHHHCCHHHHH | 36.98 | 30266825 | |
| 94 | Succinylation | ALQELLSKGLIKLVS HHHHHHHCCHHHHHH | 58.67 | - | |
| 94 | Succinylation | ALQELLSKGLIKLVS HHHHHHHCCHHHHHH | 58.67 | 23954790 | |
| 94 | 2-Hydroxyisobutyrylation | ALQELLSKGLIKLVS HHHHHHHCCHHHHHH | 58.67 | - | |
| 94 | Ubiquitination | ALQELLSKGLIKLVS HHHHHHHCCHHHHHH | 58.67 | 23000965 | |
| 94 | Acetylation | ALQELLSKGLIKLVS HHHHHHHCCHHHHHH | 58.67 | 19608861 | |
| 98 | 2-Hydroxyisobutyrylation | LLSKGLIKLVSKHRA HHHCCHHHHHHHHCC | 48.13 | - | |
| 98 | Malonylation | LLSKGLIKLVSKHRA HHHCCHHHHHHHHCC | 48.13 | 26320211 | |
| 98 | Acetylation | LLSKGLIKLVSKHRA HHHCCHHHHHHHHCC | 48.13 | 25953088 | |
| 98 | Ubiquitination | LLSKGLIKLVSKHRA HHHCCHHHHHHHHCC | 48.13 | 23000965 | |
| 102 | Ubiquitination | GLIKLVSKHRAQVIY CHHHHHHHHCCEEEE | 29.63 | - | |
| 109 | Phosphorylation | KHRAQVIYTRNTKGG HHCCEEEEECCCCCC | 10.78 | 28152594 | |
| 110 | Phosphorylation | HRAQVIYTRNTKGGD HCCEEEEECCCCCCC | 13.30 | 28152594 | |
| 114 | Ubiquitination | VIYTRNTKGGDAPAA EEEECCCCCCCCCCC | 65.53 | 22817900 | |
| 114 | Acetylation | VIYTRNTKGGDAPAA EEEECCCCCCCCCCC | 65.53 | 25953088 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS25_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS25_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS25_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52; LYS-60; LYS-66 ANDLYS-94, AND MASS SPECTROMETRY. | |